Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Computational Biology (1)
- Advanced Manufacturing (2)
- Biology and Environment (66)
- Biology and Soft Matter (1)
- Clean Energy (36)
- Climate and Environmental Systems (1)
- Computer Science (2)
- Fusion and Fission (3)
- Fusion Energy (1)
- Materials (26)
- Materials for Computing (5)
- National Security (15)
- Neutron Science (40)
- Nuclear Science and Technology (1)
- Quantum information Science (2)
- Supercomputing (50)
News Type
Date
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.